In US and Canada Call Toll Free: (877) 597-9236
Everywhere Else Call: (760) 431-6300

Synthetic Biology Building Momentum with Researchers

Mason Brooks

31st Jan, 2014

Blog, Polls

0

With the explosion of biological data now available as a direct result of genome sequencing initiatives, use of commercial gene synthesis and pre-designed synthetic biology tools is becoming increasingly popular. We wanted to understand how molecular cloners feel about using synthetic biology tools as replacements for in-house methods such as cloning. So, in December 2013, we polled users of…

read more >

Customer Opinion on Most Flexible Pricing Options – Life Science Reagent and Instrument Suppliers

percepta

1st Oct, 2013

Blog, Polls

0

We set out to understand, at a top level, which life science suppliers are recognized in the industry for having the most flexible pricing options, for reagents and for instruments.  The questions posed to North American, European and Chinese audiences were:

Q. Which life science reagent supplier has the most flexible pricing options?

Q. Which life science instrument supplier…

read more >

Customer Opinion on Most Memorable Life Science Reagent and Instrument Advertisements

percepta

10th Sep, 2013

Blog, Polls

0

We set out to understand, at a top level, which life science suppliers are recognized in the industry for having the most memorable advertising, for reagents and for instruments.  The questions posed to North American, European and Chinese audiences were:

Q. Which life science reagent supplier has the most memorable advertising?

Q. Which life science instrument supplier has the…

read more >

Poll of Fluorescent Imaging Reagent User Budgets Reveals Commercial Users more Optimistic

percepta

12th Feb, 2013

Blog, Polls

0

In February 2013 we polled our panel of fluorescent imaging reagent users regarding their anticipated laboratory budget. Data reveals that commercial users anticipate a slight increase compared to academic users. As shown in the table, 24.1% of commercial users of fluorescent imaging reagents expect their budget to increase over the next 12 months, vs. 17.6% of academic users (a…

read more >

Take Another Look at Cell Therapy

percepta

5th Feb, 2013

Blog, Polls

0

If you thought cell therapy had suffered too many setbacks in recent years and was stuck in neutral – think again. In a recent Percepta poll of 250 randomly selected life science researchers working in biotechnology and pharmaceutical companies more than 20% are involved in projects focused on allogeneic or autologous cell therapy and/or regenerative medicine. Even more surprising…

read more >

Copyright © 2021 Percepta Associates Inc. All rights reserved. Terms & Conditions.